QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.

Abroad (travel likely)RecruitingPHASE3

Conditions

Nasopharyngeal Cancinoma (NPC) · Nasopharyngeal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Fujian Cancer Hospital, Fuzhou, Fujian, China

    Contact: Study coordinator (Chuan-Ben Chen)
    Contact: Study coordinator (Su-Fang Qiu)
  • Dongguan People's Hospital, Dongguan, Guangdong, China

    Contact: Study coordinator (Zhi-Gang Liu)
  • First People's Hospital of Foshan, Foshan, Guangdong, China

    Contact: Study coordinator (Ning Zhang)
  • Guangzhou Panyu Central Hospital, Guangzhou, Guangdong, China

    Contact: Study coordinator (Guo-Rong Zou)
  • Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China

    Contact: Study coordinator (Jun Ma, M.D.) · majun2@mail.sysu.edu.cn · +862087343469
  • Zhongshan People's Hospital, Zhongshan, Guangdong, China

    Contact: Study coordinator (Feng Lei)
  • Cancer Hospital of Guangxi Medical University, Nanning, Guangxi, China

    Contact: Study coordinator (Xiao-Dong Zhu, M.D.)
  • Cancer Hospital of Guizhou Medical University, Guiyang, Guizhou, China

    Contact: Study coordinator (Feng Jin, M.D.)
  • Hubei Province Cancer Hosiptal, Wuhan, Hubei, China

    Contact: Study coordinator (De-Sheng Hu, M.D.)
  • Renmin Hospital of Wuhan University, Wuhan, Hubei, China

    Contact: Study coordinator (Xiang-Pan Li, M.D.)
  • Tongji Hospital Affiliated with Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China

    Contact: Study coordinator (Guang-Yuan Hu, M.D.)
  • Union Hospital Affiliated with Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China

    Contact: Study coordinator (Kun-Yu Yang, M.D.)
  • Hunan Cancer Hospital, Changsha, Hunan, China

    Contact: Study coordinator (Ya-Qian Han)
  • Xiangya Hospital of Central South University, Changsha, Hunan, China

    Contact: Study coordinator (Liang-Fang Shen, M.D.)
  • Jiangsu Cancer Hospital, Nanjing, Jiangsu, China

    Contact: Study coordinator (Xia He, M.D.)
  • The Eye and ENT Hospital of Fudan University, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Xiao-Shen Wang, M.D.)
  • Sichuan Cancer Hospital, Chengdu, Sichuan, China

    Contact: Study coordinator (Shi-chuan Zhang, M.D.)
  • Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Pei-guo Wang, M.D.)
  • The First Affiliated Hospital of Xiamen University, Fujian, Xiamen, China

    Contact: Study coordinator (Qin Lin, M.D.)
Study leads
  • Jun Ma, M.D.

    Principal Investigator

    Sun Yat-sen University